Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1

M Colomer-Lluch, A Ruiz, A Moris… - Frontiers in …, 2018 - frontiersin.org
Antiviral restriction factors are host cellular proteins that constitute a first line of defense
blocking viral replication and propagation. In addition to interfering at critical steps of the …

APOBEC enzymes as targets for virus and cancer therapy

ME Olson, RS Harris, DA Harki - Cell chemical biology, 2018 - cell.com
Human DNA cytosine-to-uracil deaminases catalyze mutations in both pathogen and
cellular genomes. APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H restrict human …

Medicinal chemistry strategies toward host targeting antiviral agents

X Ji, Z Li - Medicinal Research Reviews, 2020 - Wiley Online Library
Direct‐acting antiviral agents (DAAs) represent a class of drugs targeting viral proteins and
have been demonstrated to be very successful in combating viral infections in clinic …

HIV accessory proteins versus host restriction factors

K Strebel - Current opinion in virology, 2013 - Elsevier
Highlights•Host restriction factors are part of the innate immune system.•HIV encodes
accessory proteins to control host restriction factors.•Vif degrades APOBEC3G and inhibits …

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

Y Feng, TT Baig, RP Love, L Chelico - Frontiers in microbiology, 2014 - frontiersin.org
The APOBEC3 restriction factors are a family of deoxycytidine deaminases that are able to
suppress replication of viruses with a single-stranded DNA intermediate by inducing …

Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein

T Pan, X He, B Chen, H Chen, G Geng, H Luo… - European journal of …, 2015 - Elsevier
Abstract Human APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-
like 3G, A3G) is a potent restriction factor against human immunodeficiency virus type 1 (HIV …

Mechanistic insight into antiretroviral potency of 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a long-lasting effect on HIV-1 prevention

L Sun, Y Peng, W Yu, Y Zhang, L Liang… - Journal of Medicinal …, 2020 - ACS Publications
In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine
(FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its …

Host restriction factors in retroviral infection: promises in virus-host interaction

YH Zheng, KT Jeang, K Tokunaga - Retrovirology, 2012 - Springer
Retroviruses have an intricate life cycle. There is much to be learned from studying retrovirus-
host interactions. Among retroviruses, the primate lentiviruses have one of the more complex …

Inhibitory activities of indolizine derivatives: a patent review

KM Dawood, AA Abbas - Expert Opinion on Therapeutic Patents, 2020 - Taylor & Francis
Introduction Indolizines are structural isomers with indoles. Although several indole-based
commercial drugs are available in the market, none of the indolizine-based drugs are …

Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses

Y He, J Zhou, H Gao, C Liu, P Zhan, X Liu - European Journal of Medicinal …, 2023 - Elsevier
Viral infections are amongst the most prevalent diseases that pose a significant threat to
human health. Targeting viral proteins or host factors represents two primary strategies for …